nitroglycerin
Enable an agent to recognise nitroglycerin, assess its documented material state and hazards, and determine which uses or handling decisions require formulation-specific evidence and qualified authority.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to recognise nitroglycerin, assess its documented material state and hazards, and determine which uses or handling decisions require formulation-specific evidence and qualified authority.
Nitroglycerin, also called glyceryl trinitrate, is the nitrate ester of glycerol with molecular formula C3H5N3O9, an energetic organic compound used in explosives and, in controlled pharmaceutical formulations, as a vasodilator.
It can be Resolve nitroglycerin and glyceryl trinitrate references to one chemical identity while preserving separate product identities.; Compare a material declaration or analytical report with the required identity, composition and grade evidence.; Determine whether a cited property or hazard assessment applies to the recorded concentration, matrix and physical state.; Identify missing evidence or a material change that requires assessment by a qualified specialist.; Route medicinal, industrial, transport and exposure questions to the appropriate product model, authority or professional.; Record unresolved conditions and restrict conclusions when the available evidence does not support an action..
Distinguishing features
Chemical identity must establish glyceryl trinitrate, a nitrate ester, rather than glycerol, an inorganic nitrate salt or a compound identified only by a generic explosive label.
The name glyceryl trinitrate can denote the same substance; it does not by itself establish pharmaceutical grade or a medicinal product.
A material containing nitroglycerin must be distinguished from the substance itself by identifying its concentration and carrier or matrix.
Nitroglycerin must be distinguished from related nitrate esters and medicinal organic nitrates through verified structural identity and identifiers.
Medicinal and explosive contexts concern the same chemical identity but do not establish interchangeable formulations, grades or permitted actions.
Scope
+ Chemical identity and verified registry identifiers for nitroglycerin
+ Purity, concentration, impurities and the material context in which nitroglycerin is present
+ Physical properties and phase under stated conditions
+ Energetic instability, exposure hazards and evidence relevant to the actual material form
+ Substance-level relationships to medicinal and industrial uses
+ Classification, documentation and restrictions tied to jurisdiction and formulation
- Synthesis, nitration procedures and manufacturing process design
- Explosive formulation recipes, initiation methods and device construction
- Complete models of dynamite, propellants or other explosive products containing nitroglycerin
- Complete models of tablets, sprays, patches, infusions or other medicinal products
- Patient diagnosis, prescribing and individual dosing decisions
- Facility engineering, transport operations and emergency response procedures
Characteristics
- Verified chemical identity
- Preferred name, synonyms, molecular formula, structural representation and verified CAS, PubChem and EC identifiers Prevents confusion between the substance, related compounds and products marketed under application-specific names.
- Nitroglycerin content
- Mass fraction %, mass concentration with units, or amount per product unit; specify analytical basis and uncertainty Content determines whether evidence about a particular preparation is applicable and prevents confusion between purity, concentration and medicinal strength.
- Carrier or matrix
- Links to identified solvent, diluent, absorbent or other formulation components Material behaviour and applicable classifications cannot be inferred from the nitroglycerin name alone.
- Grade and impurity profile
- Declared grade, governing specification, measured impurities and conformity status An industrial material cannot be assumed suitable for medicinal use, and a grade label needs supporting evidence.
- Physical state
- Observed phase, homogeneity and phase separation, with temperature, pressure and observation time The actual material state may differ from a reference description of the pure substance.
- Physical-property evidence
- Density in kg/m³, phase-transition temperature in °C and vapour pressure in Pa, each with conditions and source Supports interpretation of state without applying unqualified reference constants to a different formulation.
- Thermal behaviour
- Reported transition or decomposition result, temperature in °C, method, pressure and specimen composition Distinguishes measured thermal events and decomposition from an assumed ordinary boiling point.
- Energetic-hazard evidence
- Applicable test reports and classifications, with specimen form, method, date and limitations Sensitivity and energetic behaviour require evidence relevant to the material being assessed.
- Exposure criteria
- Applicable limit in ppm or mg/m³, averaging period, route, skin notation, jurisdiction and effective date Exposure values are incomplete without their authority, time basis and route qualifications.
- Biological-effect context
- Intended pharmacological effect, adverse-effect evidence and exposure route Separates controlled medicinal use from unintended exposure and prevents transferring clinical assumptions between routes.
- Regulatory classification
- Jurisdiction-specific hazard, transport and medicinal status linked to material form and current source A substance identifier alone does not determine every applicable legal or transport classification.
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 18 findings · 28 questions.
Chemical identity and material boundary Establish what is nitroglycerin and what is a preparation containing it.
The same substance appears under chemical, medicinal and industrial terminology, making identity and product boundaries essential.
Identity and synonyms
Connect names and identifiers to a verified nitrate-ester structure.
Nitroglycerin identity test
Require evidence that the named substance is glyceryl trinitrate rather than glycerol, another nitrate ester or an unspecified nitrate.
- Which structural identity and authoritative identifiers establish that this record concerns nitroglycerin? definition
- Which sources verify that the recorded synonyms refer to the same substance? provenance
Composition and grade
Describe nitroglycerin content and the surrounding material without collapsing the preparation into the substance.
Substance versus preparation
Separate chemical purity, formulation concentration, grade and product strength.
- Does the record describe the substance, a solution, an absorbed material or a finished product, and which neighbouring model owns the preparation? boundary
- What analysis establishes nitroglycerin content, its reporting basis, relevant impurities and conformity to the declared grade? measurement
Physical state and property evidence Represent the observed material state and the conditions attached to physical-property claims.
Reference values for pure nitroglycerin cannot automatically describe diluted, absorbed or otherwise formulated material.
Phase and homogeneity
Record phase, uniformity and changes relevant to the actual specimen.
Condition-dependent state
Treat phase and homogeneity as observations tied to composition, conditions and time.
- What phase and degree of homogeneity are documented at the recorded temperature and pressure? measurement
- Is there evidence of crystallisation, separation or another physical change that makes the existing assessment inapplicable? boundary
Reference properties and thermal events
Qualify physical constants and distinguish thermal transitions from decomposition.
Property applicability
Associate every property value with its specimen, method and conditions instead of supplying a universal constant without qualifications.
- Which measured density, vapour-pressure and phase-transition values apply to the stated composition and conditions? measurement
- Does a reported high-temperature value represent boiling, decomposition or another event, and what source and method establish that interpretation? provenance
Energetic hazard and condition assessment Capture evidence about explosive hazards and whether a material remains within an assessed condition.
Nitroglycerin requires explicit energetic-hazard reasoning that cannot be replaced by ordinary chemical identity or a generic safety label.
Form-specific hazard evidence
Tie energetic-hazard conclusions to the actual material form and documented assessment.
Energetic assessment boundary
Record the scope and limits of qualified hazard evidence without turning it into experimental or handling instructions.
- Which authoritative assessment addresses energetic hazards for this concentration, carrier and physical form? provenance
- Which differences between the assessed specimen and the present material prevent transferring its conclusions? boundary
Condition history and escalation
Track material changes and the limits of an agent's authority to judge continued suitability.
Reassessment triggers
Make uncertainty about contamination, formulation changes or undocumented history visible to a qualified assessor.
- What documented changes in composition, containment or environmental history require review under the applicable assessment? provenance
- Which decisions must be deferred to a qualified specialist when the material history or condition is unresolved? action
Biological effects and exposure Separate medicinal pharmacology from unintended exposure while preserving their shared substance identity.
Nitroglycerin's medicinal role and exposure hazards must coexist in the model without treating medicinal availability as evidence of general handling suitability.
Medicinal role boundary
Link substance-level pharmacology to the specific authorised medicinal product and route.
Pharmacology versus prescribing
Record the documented vasodilator role while assigning indications, administration and patient decisions to clinical and product models.
- What authoritative pharmacological evidence explains nitroglycerin's medicinal role and relevant adverse effects? provenance
- Which claims depend on a particular medicinal formulation, route or patient context and therefore belong outside this substance model? boundary
Occupational and unintended exposure
Represent route-specific exposure evidence and applicable occupational criteria.
Exposure evidence and limits
Require exposure criteria to carry units, time basis, route qualifications and issuing authority.
- Which exposure routes, including potential skin absorption, are addressed by the authoritative assessment for this material? provenance
- Which occupational limits and skin notations apply in the relevant jurisdiction, with what units and averaging periods? measurement
Authorised use and regulatory identity Connect verified material identity to use-specific documentation and applicable classifications.
Medicinal status, chemical hazard classification and transport classification answer different questions and may depend on formulation.
Classification applicability
Record classifications with their legal scope, material description and effective date.
Classification with context
Prevent a hazard or transport designation for one nitroglycerin preparation from becoming a universal property of every preparation.
- Which current chemical-hazard and transport classifications explicitly match the recorded material form and composition? provenance
- What jurisdiction, transport mode or product-status conditions limit each classification's applicability? boundary
Use eligibility and documentation
Determine whether evidence supports referral into a particular medicinal or industrial use context.
Documented use eligibility
Treat chemical identity as necessary but insufficient evidence for suitability or permission to use a material.
- Which specifications, supplier records and applicable authorisations establish eligibility for the proposed use? provenance
- What may the agent conclude from those records, and which release or use decisions require the responsible product owner or qualified authority? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- These are recalled facts, not researched or source-verified findings.
- Confirm phase-dependent physical constants and purity conditions; nitroglycerin has polymorphic behavior and decomposes rather than offering a straightforward normal boiling-point measurement.
- Verify exact hazard classifications, exposure limits, transport entries and pharmacopoeial requirements for the relevant formulation and jurisdiction.
- Which of these check these first hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- CAS Registry Number - 55-63-0 - Identifies the chemical substance, not a particular explosive mixture or medicine.
- PubChem CID - 4510 - Compound identifier for nitroglycerin.
- EC number - 200-240-8 - European chemical inventory identifier.
- Which of these identifiers and schemes hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Standards and regulation
Recalled without web access and unsourced; every item is a lead to verify.
- United Nations Globally Harmonized System of Classification and Labelling of Chemicals provides the framework for communicating physical and health hazards; applicable classifications depend on composition and adopted jurisdictional rules.
- United Nations Recommendations on the Transport of Dangerous Goods distinguish transport entries according to formulation and desensitization.
- United States Pharmacopeia-National Formulary, issued by the United States Pharmacopeial Convention, includes quality standards for nitroglycerin pharmaceutical articles.
- Which of these standards and regulation hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Active ingredient in medicines used to relieve or prevent angina.
- Intravenous pharmaceutical formulations used for selected cardiovascular indications under clinical supervision.
- Ingredient in dynamite and other formulated commercial explosives.
- Energetic ingredient in some propellants.
- Which of these real-world use hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Molar mass - 227.09 - g/mol
- Melting point of the stable crystalline form - Approximately 13.2 - °C
- Liquid density near 20 °C - Approximately 1.59 - g/cm³
- Which of these typical measurements hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Unformulated nitroglycerin is highly sensitive to mechanical shock and can detonate.
- Heating or fire can cause violent decomposition and explosion.
- Absorption through skin or other exposure routes can cause headache, dizziness and a dangerous fall in blood pressure.
- Pharmaceutical use with phosphodiesterase-5 inhibitors can produce severe hypotension.
- Loss of desensitizer or separation within a formulation can change its explosive hazard.
- Which of these failure modes and hazards hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Medicines may be labelled nitroglycerin or glyceryl trinitrate, often abbreviated GTN.
- Medicinal authorization, occupational exposure limits and explosives controls vary by jurisdiction.
- Transport classification depends on the actual preparation rather than the substance name alone.
- Which of these regional variation hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- glycerol - Glycerol has three hydroxyl groups; nitroglycerin has their corresponding nitrate ester groups.
- dynamite - Dynamite is a formulated explosive material, whereas nitroglycerin is an individual chemical substance that may be an ingredient.
- nitroglycerin medicine - A medicine is a specified dosage form containing controlled amounts of the substance and other ingredients.
- trinitrotoluene - TNT is an aromatic nitro compound with carbon-nitrogen bonds to its nitro groups; nitroglycerin is a nitrate ester with carbon-oxygen-nitrogen linkages.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of nitroglycerin this model covers, and on what evidence? provenance
What the second pass must settle
- Which authoritative identity records should anchor the CAS number, PubChem CID, EC number and accepted synonym set?
- Which physical-property values are adequately supported, particularly phase transitions and reported boiling or decomposition behaviour under specified conditions?
- How should the publication distinguish hazard evidence for pure nitroglycerin from evidence for solutions, absorbed preparations and medicinal formulations?
- Which jurisdictions and intended-use contexts should the initial publication cover for current hazard classifications, transport entries and occupational exposure limits?
- Does an existing Vercy world model already cover this chemical identity, and which product or clinical models should receive the out-of-scope relationships?